1 |
Alfaleh MA, Fahmy O, Al-Rabia MW, Abourehab MAS, Ahmed OAA, Fahmy UA, H Alsulimani H, Badr-Eldin SM, Aldawsari HM, Aldhabi BM, Alharbi AS, Alhakamy NA. Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer. Sci Rep 2022;12:19446. [PMID: 36376469 DOI: 10.1038/s41598-022-24151-3] [Reference Citation Analysis]
|
2 |
He X, Wang N, Zhang Y, Huang X, Wang Y. The therapeutic potential of natural products for treating pancreatic cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1051952] [Reference Citation Analysis]
|
3 |
Hashemi M, Mirzaei S, Barati M, Hejazi ES, Kakavand A, Entezari M, Salimimoghadam S, Kalbasi A, Rashidi M, Taheriazam A, Sethi G. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects. Life Sci 2022;309:120984. [PMID: 36150461 DOI: 10.1016/j.lfs.2022.120984] [Reference Citation Analysis]
|
4 |
Maheshwari N, Sharma MC. Laser empowered ‘chemo-free’ phytotherapy: Newer approach in anticancer therapeutics delivery. Journal of Drug Delivery Science and Technology 2022;75:103709. [DOI: 10.1016/j.jddst.2022.103709] [Reference Citation Analysis]
|